Company facts
- Industry
- Pharmaceutical Preparations
- Headquarters
- Dublin 4
- Most recent report
- 10-Q, filed Nov 3, 2026
- Incorporated
- N/A
- Filings on record
- 1,000+ filings
- On EDGAR
- CIK 1520262
- Fiscal year ends
- December
- Filer status
- Large accelerated filer
Financials 8 of 41
News 8 of 136
Prospectuses and Registrations 8 of 14
- S-8 Registration statement for an employee plan Jul 28, 2026
- S-8 Registration statement for an employee plan Jul 29, 2025
- S-8 Registration statement for an employee plan Jul 24, 2024
- S-8 Registration statement for an employee plan Jul 26, 2023
- S-8 Registration statement for an employee plan Jul 27, 2022
- S-8 Registration statement for an employee plan Jul 28, 2021
- S-8 Registration statement for an employee plan Jul 29, 2020
- S-8 POS Post-effective amendment to an employee plan registration Jul 29, 2020
Proxies 8 of 57
- DEFA14A Extra proxy material May 13, 2026
- DEFA14A Extra proxy material Apr 6, 2026
- DEF 14A Proxy statement for a shareholder vote Apr 6, 2026
- PRE 14A Preliminary proxy statement Mar 27, 2026
- DEFA14A Extra proxy material May 12, 2025
- DEFA14A Extra proxy material Apr 7, 2025
- DEF 14A Proxy statement for a shareholder vote Apr 7, 2025
- PRE 14A Preliminary proxy statement Mar 28, 2025
Ownership 8 of 718
- 4 Insider reported a trade Nov 3, 2026
- 144 Notice of a proposed sale of restricted stock Nov 3, 2026
- 4 Insider reported a trade Oct 9, 2026
- 4 Insider reported a trade Oct 9, 2026
- 4 Insider reported a trade Oct 2, 2026
- 144 Notice of a proposed sale of restricted stock Oct 2, 2026
- 3 Insider reported their initial holding Sep 18, 2026
- 4 Insider reported a trade Sep 3, 2026
Other 8 of 34
Everything here comes from Alkermes plc.'s own filings on SEC EDGAR. The filing list is rechecked every hour.